Dashenlin Pharmaceutical Group guarantees 470m yuan for subsidiaries' credit lines

Dashenlin Pharmaceutical Group Co., Ltd. has announced it has provided a total guarantee of 470 million yuan for its five controlling subsidiaries to secure comprehensive credit lines from banks. The beneficiaries include Henan Dashenlin Pharmaceutical Logistics Co., Ltd., Guangxi Nanning Dashenlin Pharmaceutical Co., Ltd., Guangxi Dashenlin Pharmaceutical Co., Ltd., Chongqing Wanjiaoyan Pharmacy Chain Co., Ltd., and Dashenlin (Liaoning) Pharmaceutical Co., Ltd. These guarantees are structured as joint and several liabilities, covering various financial services.

The decision was approved at the company's Fourth Board of Directors' Twenty-Fifth Meeting on April 24, 2025, and the 2024 Annual General Meeting on May 20, 2025. The total guaranteed amount falls within the authorized limit of up to 7.765 billion yuan for 2025. As of the announcement date, the total outstanding external guarantees by Dashenlin Pharmaceutical Group and its subsidiaries amount to 324,750,000 yuan, representing 39.90% of the company's latest audited net assets attributable to shareholders.

All guaranteed entities are within Dashenlin Pharmaceutical Group's consolidated reporting scope, demonstrating healthy operations and stable financial conditions, thereby mitigating potential risks. There are no overdue external guarantees, nor has the company provided guarantees for its controlling shareholders, actual controllers, or their related parties.